Tag: Skin Disorders: Misc.
Factors ID’d That Affect Medical Decision-Making in Hidradenitis Suppurativa
Five factors identified, including suffering threshold, perceptions of treatment risk, treatment fatigue
Unapproved ‘Fat-Dissolving’ Injections Are Leaving Patients Maimed, FDA Warns
One in Five New Dermatology Drugs Were First in Class Over the Past Decade
Furthermore, nearly four in 10 new dermatologic drug approvals were deemed clinically useful
Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care
Educational intervention successfully increased barbers’ knowledge of causes, prevention, and treatment
Ichthyosis Tied to Increased Risk for Depression, Anxiety
Authors say results suggest the need for increased screening in patients with ichthyosis
Skin Diseases Pose a Psychosocial Burden
Effect seen on patients' daily and work life
Nemolizumab Improves Symptoms in Prurigo Nodularis
Treatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response
Sexual, Gender Minorities With Chronic Skin Diseases More Likely to Face Barriers to Care
Cost and noncost barriers more likely for sexual and gender-minority patients with chronic inflammatory skin diseases
Dupilumab Treatment Beneficial for Sleep in Atopic Dermatitis
12 weeks of treatment also yields benefits in peak pruritus, change in SCORing Atopic Dermatitis
FDA Approves Topical Treatment for Molluscum Contagiosum
Ycanth approved for adults and children older than 2 years
